Stay updated on Pembrolizumab in Newly Diagnosed Glioblastoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Newly Diagnosed Glioblastoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Newly Diagnosed Glioblastoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Visual/UI updates to the study page with no changes to core study content; to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T21:30:46.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    32 days ago
    Change Detected
    Summary
    - Added a government-operating-status notice and a link to official sources, indicating the page may have dynamic status information. - Updated version from v3.1.0 to v3.2.0, signaling a new release.
    Difference
    4%
    Check dated 2025-10-06T07:50:48.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    Changed the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.
    Difference
    0.1%
    Check dated 2025-09-29T04:11:31.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Version bump to v3.0.2 and removal of the 'Back to Top' link; no substantive content changes.
    Difference
    0.2%
    Check dated 2025-09-14T21:46:39.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.2%
    Check dated 2025-09-07T18:13:19.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The page has undergone significant changes, including the removal of detailed information about various neoplasms and pharmacological agents, while retaining the facility name and location details.
    Difference
    3%
    Check dated 2025-08-31T12:23:56.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Newly Diagnosed Glioblastoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Newly Diagnosed Glioblastoma Clinical Trial page.